ADIL
Adial Pharmaceuticals Inc
Stock NASDAQ – Stock Market Prices, News & Analysis
Adial Pharmaceuticals develops drug treatments to combat addictions, including alcoholism.
Adial Pharmaceuticals Inc
ADIL
Adial Pharmaceuticals develops drug treatments to combat addictions, including alcoholism.
Price history of Adial Pharmaceuticals Inc
Price history of Adial Pharmaceuticals Inc
Performance & Momentum
Strategic Analysis
Adial Pharmaceuticals Inc • 2026
Adial Pharmaceuticals positions itself in the American biotechnology sector by developing innovative treatments targeting addictions, including alcoholism. Its model is based on a therapeutic niche with high medical need and significant disruptive potential, although clinical development remains to be confirmed.
- Focus on a medical market segment with high unmet demand
- Expertise in developing treatments targeting addiction disorders
- Differentiating potential related to the specificity of its molecules
- Very weak stock performance over several years indicating a lack of confidence or operational difficulties
- Recent absence of significant news or visible clinical progress
The momentum is extremely negative with a free fall in performance over the medium and long term, highlighting a loss of investor support. The lack of recent catalysts indicates a high risk, suggesting that the stock remains speculative and requires increased vigilance.
Similar stocks to Adial Pharmaceuticals Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
